BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34167617)

  • 21. Identification of cancer-related gene network in hepatocellular carcinoma by combined bioinformatic approach and experimental validation.
    Ni W; Zhang S; Jiang B; Ni R; Xiao M; Lu C; Liu J; Qu L; Ni H; Zhang W; Zhou P
    Pathol Res Pract; 2019 Jun; 215(6):152428. PubMed ID: 31064721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis.
    Chen Z; Chen J; Huang X; Wu Y; Huang K; Xu W; Xie L; Zhang X; Liu H
    J Comput Biol; 2019 May; 26(5):485-494. PubMed ID: 30864827
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
    Li Z; Xu J; Cui H; Song J; Chen J; Wei J
    Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 28. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinformatics analysis for hepatocellular carcinoma genes based on the data of expression profile chip.
    Xiao J; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1053-1060. PubMed ID: 33051418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients.
    Zhang X; Yin S; Ma K
    J Int Med Res; 2020 Jun; 48(6):300060520932112. PubMed ID: 32567431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of prognostic biomarkers for patients with hepatocellular carcinoma after hepatectomy.
    Wang X; Liao X; Yang C; Huang K; Yu T; Yu L; Han C; Zhu G; Zeng X; Liu Z; Zhou X; Qin W; Su H; Ye X; Peng T
    Oncol Rep; 2019 Mar; 41(3):1586-1602. PubMed ID: 30628708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis.
    Liu F; Wu Y; Mi Y; Gu L; Sang M; Geng C
    Pathol Res Pract; 2019 Jul; 215(7):152436. PubMed ID: 31076281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis.
    Wu M; Liu Z; Zhang A; Li N
    Medicine (Baltimore); 2019 Feb; 98(5):e14287. PubMed ID: 30702595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma.
    Li N; Li L; Chen Y
    Oxid Med Cell Longev; 2018; 2018():3478305. PubMed ID: 29977454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.